University of Utah spin-off awarded grant to develop new antibiotics

(University of Utah) Curza Global, LLC (Curza), a company based on technology developed at the University of Utah, has been awarded a Phase I Small Business Innovation Research (SBIR) grant of $598,770 entitled 'Natural product-inspired antibacterials with unique ribosomal binding' that will provide two years of support. Curza is a pharmaceutical startup company focused on small-molecule therapeutics. Curza's technology originates from the laboratories of Ryan Looper and Dustin Williams, both professors at the University of Utah.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news